Endocannabinoid basis of personality—Insights from animal model of social behavior

Endocannabinoid basis of personality—Insights from animal model of social behavior

Rationale: The endocannabinoid system is known to be involved in learning, memory, emotional processing and regulation of personality patterns. Here we assessed the endocannabinoid profile in the brains of mice with strong characteristics of social dominance and submissiveness.Methods: A lipidomics...

Full description

Bibliographic Details
Main Authors:	Natalya M. Kogan, Dilorom Begmatova, Liudmila Vinnikova, Sergey Malitsky, Maxim Itkin, Eyal Sharon, Artem Klinov, Jonathan Gorelick, Igor Koman, Zvi Vogel, Raphael Mechoulam, Albert Pinhasov
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-08-01
Series:	Frontiers in Pharmacology
Subjects:	personality endocannabinoidome social behavior dominance submissiveness endocannabinoid system
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1234332/full

Similar Items

(Wh)olistic (E)ndocannabinoidome-Microbiome-Axis Modulation through (N)utrition (WHEN) to Curb Obesity and Related Disorders
by: Jyoti Sihag, et al.
Published: (2022-01-01)

Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models
by: Clara Depommier, et al.
Published: (2021-01-01)

The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation
by: Fabio Arturo Iannotti, et al.
Published: (2021-03-01)

Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis
by: Armita Abolghasemi, et al.
Published: (2021-11-01)

Targeted Glioma Therapy—Clinical Trials and Future Directions
by: Aleksandr Shikalov, et al.
Published: (2024-01-01)

Pharmacohistory of Cannabis Use—A New Possibility in Future Drug Development for Gastrointestinal Diseases
by: Dinesh Thapa, et al.
Published: (2023-09-01)

Mutual Links between the Endocannabinoidome and the Gut Microbiome, with Special Reference to Companion Animals: A Nutritional Viewpoint
by: Aniello Schiano Moriello, et al.
Published: (2022-01-01)

Beneficial Effects of <i>Akkermansia muciniphila</i> Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists
by: Clara Depommier, et al.
Published: (2021-01-01)

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
by: Berhanu Geresu Kibret, et al.
Published: (2022-01-01)

The diet rapidly and differentially affects the gut microbiota and host lipid mediators in a healthy population
by: Isabelle Bourdeau-Julien, et al.
Published: (2023-02-01)

Hepatitis C Virus Infection Upregulates Plasma Phosphosphingolipids and Endocannabinoids and Downregulates Lysophosphoinositols
by: Diren Beyoğlu, et al.
Published: (2023-01-01)

Cannabinoid Quinones—A Review and Novel Observations
by: Natalya M. Kogan, et al.
Published: (2021-03-01)

Impact of selenium on the intestinal microbiome-eCBome axis in the context of diet-related metabolic health in mice
by: Fredy Alexander Guevara Agudelo, et al.
Published: (2022-11-01)

Commentary: Comment on the Effect of Endocannabinoid System on Rat Behavior
by: Ali Roohbakhsh
Published: (2017-01-01)

The Endocannabinoid System: A Potential Therapeutic Target for Coagulopathies
by: Wujood Khayat, et al.
Published: (2022-06-01)

Role and Function of Endocannabinoid System in Major Depressive Disease
by: Erhan Yarar
Published: (2020-12-01)

Cannabinoid Receptor 2 Blockade Prevents Anti-Depressive-like Effect of Cannabidiol Acid Methyl Ester in Female WKY Rats
by: Danielle Hen-Shoval, et al.
Published: (2023-02-01)

Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage
by: Riccardo Vago, et al.
Published: (2020-04-01)

Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
by: Stephen Schultz, et al.
Published: (2021-03-01)

Endocannabinoids and Schizophrenia
by: Stéphane Potvin, et al.
Published: (2010-10-01)

Non-opioid Analgesics and the Endocannabinoid System
by: Ruhan Deniz Topuz, et al.
Published: (2020-11-01)

Chemism and the role of endocannabinoids in physiological processes
by: Prerad Ranka, et al.
Published: (2017-01-01)

Oral Capsaicinoid Administration Alters the Plasma Endocannabinoidome and Fecal Microbiota of Reproductive-Aged Women Living with Overweight and Obesity
by: Claudia Manca, et al.
Published: (2021-09-01)

Renal Endocannabinoid Dysregulation in Obesity-Induced Chronic Kidney Disease in Humans
by: Anna Permyakova, et al.
Published: (2023-09-01)

Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC/MS/MS
by: Flaminia Fanelli, et al.
Published: (2012-03-01)

Endocannabinoid Systetm: Neuropharmacological Implications
by: Vivek Kumar Sharma, et al.
Published: (2016-06-01)

Microglial Endocannabinoid Signalling in AD
by: Lucia Scipioni, et al.
Published: (2022-04-01)

Expression of the endocannabinoid receptors in human fascial tissue
by: C. Fede, et al.
Published: (2016-06-01)

BIONOTE as an Innovative Biosensor for Measuring Endocannabinoid Levels
by: Simone Grasso, et al.
Published: (2021-01-01)

The endocannabinoid system and stroke: A focused review
by: Bradley Kolb, et al.
Published: (2019-01-01)

Endocannabinoid System: Chemical Characteristics and Biological Activity
by: Bismarck Rezende, et al.
Published: (2023-01-01)

Alterations of the endocannabinoid system and circulating and peripheral tissue levels of endocannabinoids in sarcopenic rats
by: Olivier Le Bacquer, et al.
Published: (2022-02-01)

The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
by: Martina Rabino, et al.
Published: (2021-09-01)

Role of Endocannabinoids on Neuroinflammation in Autism Spectrum Disorder Prevention
by: Syed Shahid Habib, et al.
Published: (2017-06-01)

The endocannabinoid system and breathing
by: Beth M. Wiese, et al.
Published: (2023-04-01)

Pan-phylum In Silico Analyses of Nematode Endocannabinoid Signalling Systems Highlight Novel Opportunities for Parasite Drug Target Discovery
by: Bethany A. Crooks, et al.
Published: (2022-07-01)

The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors
by: Inés Reynoso-Moreno, et al.
Published: (2018-05-01)

Targeting the Achilles’ Heel of Multidrug-Resistant <i>Staphylococcus aureus</i> by the Endocannabinoid Anandamide
by: Ronit Vogt Sionov, et al.
Published: (2022-07-01)

Transcriptomic and Network Analyses Reveal Immune Modulation by Endocannabinoids in Approach/Avoidance Traits
by: Andrea Termine, et al.
Published: (2022-02-01)

Exploration of Multiverse Activities of Endocannabinoids in Biological Systems
by: Tapan Behl, et al.
Published: (2022-05-01)